powered by LeadingAge New York

New Admission Quarantine and Testing Reminder

On Feb. 2, 2022, the Centers for Disease Control and Prevention (CDC) updated its Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes to include recommendations for new admissions and readmissions or those residents who leave the facility for a period of time greater than 24 hours. The CDC's recommendations are provided below:

  • In general, all residents who are not up to date with all recommended COVID-19 vaccine doses and are new admissions and readmissions should be placed in quarantine, even if they have a negative test upon admission, and should be tested as described in the testing section above; COVID-19 vaccination should also be offered.
    • Facilities located in counties with low community transmission might elect to use a risk-based approach for determining which of these residents require quarantine upon admission. Decisions should be based on whether the resident had close contact with someone with SARS-CoV-2 infection while outside the facility and if there was consistent adherence to IPC practices in healthcare settings, during transportation, or in the community prior to admission.
  • In general, residents who are up to date with all recommended COVID-19 vaccine doses and residents who have recovered from SARS-CoV-2 infection in the prior 90 days do not need to be placed in quarantine but should be tested as described in the testing section above. Quarantine might be considered if the resident is moderately to severely immunocompromised.

. . .

  • Residents who leave the facility for 24 hours or longer should generally be managed as described in Section: Create a Plan for Managing New Admissions and Readmissions, including performance of recommended testing.

Adult care facility (ACF) members are reminded of this Department of Health (DOH) guidance:

Please refer to the CDC document referenced above for full recommendations and testing recommendations.

Contact: Mark Kepner-Clough, mkepner-clough@leadingageny.org, 518-728-2365